Ep4 receptor inhibitors to treat rheumatoid arthritis

Details Ep4 receptor inhibitors to treat rheumatoid arthritis Ep4 receptor inhibitors to treat rheumatoid arthritis

A - Human Necessities

61

K

A61K 31/4178 (2006.01) A61K 31/00 (2006.01) A61K 31/437 (2006.01) A61K 31/64 (2006.01) A61P 29/00 (2006.01) C07D 235/06 (2006.01) C07D 235/08 (2006.01) C07D 235/12 (2006.01) C07D 235/14 (2006.01) C07D 235/30 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 403/04 (2006.01) C07D 403/06 (2006.01) C07D 403/12 (2006.01) C07D 413/12 (2006.01) C07D 417/04 (2006.01) C07D 417/12 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01) C07D 491/04 (2006.01) C07D 521/00 (2006.01)

Patent

CA 2426487

The invention features a method of treating rheumatoid arthritis in a mammal comprising administering an agent that inhibits prostaglandin EP4 receptor (EP4) activity. Also featured is a method of identifying agents that selectively inhibit EP4 activity in vivo.

L'invention concerne une méthode destinée au traitement de la polyarthrite rhumatoïde chez un mammifère, consistant à administrer un agent inhibant l'activité du récepteur EP4 de la prostaglandine. L'invention concerne également une méthode destinée à l'identification d'agents inhibant de façon sélective l'activité du récepteur EP4 in vivo.

Affiliated with

Also associated with

Rating

Ep4 receptor inhibitors to treat rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ep4 receptor inhibitors to treat rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ep4 receptor inhibitors to treat rheumatoid arthritis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1773543